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Background: The purpose of this study was to examine the ergogenic benefits of Turkish coffee consumed an
hour before exercise. In addition, metabolic, cardiovascular, and subjective measures of energy, focus and alertness
were examined in healthy, recreationally active adults who were regular caffeine consumers (>200 mg per day).
Methods: Twenty males (n= 10) and females (n = 10), age 24.1 ± 2.9 y; height 1.70 ± 0.09 m; body mass 73.0 ± 13.0 kg
(mean ± SD), ingested both Turkish coffee [3 mg · kg−1 BW of caffeine, (TC)], and decaffeinated Turkish coffee (DC) in a
double-blind, randomized, cross-over design. Performance measures included a 5 km time trial, upper and lower body
reaction to visual stimuli, and multiple object tracking. Plasma caffeine concentrations, blood pressure (BP), heart rate and
subjective measures of energy, focus and alertness were assessed at baseline (BL), 30-min following coffee ingestion (30+),
prior to endurance exercise (PRE) and immediately-post 5 km (IP). Metabolic measures [VO2, VE, and respiratory exchange
rate (RER)] were measured during the 5 km.
Results: Plasma caffeine concentrations were significantly greater during TC (p < 0.001) at 30+, PRE, and IP compared to
DC. Significantly higher energy levels were reported at 30+ and PRE for TC compared to DC. Upper body reaction
performance (p = 0.023) and RER (p = 0.019) were significantly higher for TC (85.1 ± 11.6 “hits,” and 0.98 ± 0.05 respectively)
compared to DC (81.2 ± 13.7 “hits,” and 0.96 ± 0.05, respectively). Although no significant differences (p = 0.192)
were observed in 5 km run time, 12 of the 20 subjects ran faster (p = 0.012) during TC (1662 ± 252 s) compared to
DC (1743 ± 296 s). Systolic BP was significantly elevated during TC in comparison to DC. No other differences (p > 0.05)
were noted in any of the other performance or metabolic measures.
Conclusions: Acute ingestion of TC resulted in a significant elevation in plasma caffeine concentrations within 30-min
of consumption. TC ingestion resulted in significant performance benefits in reaction time and an increase in subjective
feelings of energy in habitual caffeine users. No significant differences were noted in time for the 5 km between trials,
however 60 % of the participants performed the 5 km faster during the TC trial and were deemed responders. When
comparing TC to DC in responders only, significantly faster times were noted when consuming TC compared to DC.
No significant benefits were noted in measures of cognitive function.
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Coffee consumption has vast commercial, agricultural,
and social importance, is pharmacologically active, and is
often consumed for its stimulatory effects [1]. Coffee is a
highly-concentrated source of caffeine (~2 %) [2–4]. The
stimulatory effects of coffee are attributed to the pharm-
acological activity of caffeine, acting as an antagonist of
adenosine receptors in the brain [5]. However, the wide
variety of coffee species, roasting conditions, and ex-
traction procedures employed results in a considerable
amount of biological variance [1, 6, 7]. Unlike coffee
traditionally consumed in the western world, Turkish
coffee is not drip filtered, but rather its method of
preparation involves slowly boiling water that is mixed
with thin powdery grounds [7]. This style of prepar-
ation results in a greater amount of biologically active
components remaining in the liquid, and likely con-
tributes to the higher concentration of caffeine found
in Turkish coffee compared to other coffee types and
preparation styles [8].
The ingestion of caffeine has been reported to spare
muscle glycogen, and increase fat oxidation through in-
creased sympathetic nervous system activity [3, 9–11].
Several reviews examining the ergogenic benefits of caf-
feine use and endurance performance have concluded
that caffeine use is positively related to greater performance
in time trials and in exercise to exhaustion [10, 12, 13]. Caf-
feine anhydrous has long been thought to be superior for
improving endurance performance as compared to coffee
due to the presence of chlorogenic acid in coffee [3, 4, 14].
Recently, Hodgson et al. [4] compared the effects of deca-
ffeinated coffee, regular coffee, caffeine anhydrous, and a
placebo and demonstrated regular coffee to be as effective
as anhydrous caffeine, when provided at the same relative
dose, for improving endurance performance [4]. Differences
in their study and others were partly attributed to the per-
formance test used. Previous studies examining the ergo-
genic benefits of coffee have used prolonged submaximal
runs [15], or using time to exhaustion tests [3, 9, 16], how-
ever Hodgson and colleagues [4] employed a time trial as
their assessment. Considering that time to exhaustion tests
have been shown to be highly variable from day to day [17],
the use of time trials may provide a more reliable measure
of endurance performance [18]. Therefore, we hypothesize
that the ingestion of Turkish coffee will improve 5 km time
trial performance, reaction time, and subjective measures
energy, focus and alertness, but will not change metabolic




Participants reported to the Human Performance La-
boratory (HPL) for one familiarization session prior toexperimental trials. During the familiarization session,
participants were informed of all procedures and famil-
iarized with all performance measures to reduce the
possibility of a learning effect. Participants performed
two experimental time trials with a minimum of 48 h
between each trial. The average time between trials was
5.3 ± 2.7 days. During each trial, participants consumed
either regular Turkish coffee (TC), or a decaffeinated
Turkish coffee (DC) from the same manufacturer (Strauss
Coffee, Lod, Israel).
Participants reported to the HPL 2-h post-prandial
and had not exercised for at least 24 h prior to each trial.
In addition, participants were asked to not alter their
dietary habits, but to replicate their dietary habits for the
day before and day of each trial, and were requested to
avoid caffeine consumption the day of the trial. Upon
arrival to the laboratory participants were asked to lie
comfortably in a supine position prior to the insertion of
a cannula. Participants were then requested to sit comfort-
ably for 15 min prior to the baseline (BL) blood draw. Fol-
lowing the BL blood draw participants were provided
either the TC or DC. Additional blood draws occurred
30-min following coffee ingestion (30+), prior to the
5 km run (PRE), and immediately following the 5 km
run (IP). Cardiovascular and subjective measures were
also assessed at similar time points. Performance mea-
sures included reaction assessment, 5 km time trial and
cognitive function. During the time trial oxygen con-
sumption (VO2), minute ventilation (VE), respiratory ex-
change ratio (RER), and heart rate (HR) were assessed.
The study protocol is depicted in Fig. 1.
Participants
For inclusion in the study, participants were required to
have a VO2peak greater than 35 ml∙kg
−1∙min−1, and had
to be regular caffeine and/or coffee consumers to increase
homogeneity of the sample. Regular consumption was de-
fined as ≥200 mg per day or ≥1 cup of coffee per day; the
reported intake was 277 ± 183 mg · day−1. After initial
testing, 23 recreationally-active individuals (men = 10,
women = 13) between the ages of 18 and 35 were re-
cruited to participate in this study. Two female partici-
pants were removed due to health reasons not associated
with the study, and one for non-compliance. Therefore,
data for 10 men (25.5 ± 1.8 y; 1.77 ± 0.05 m; 84.1 ± 7.1 kg;
48.0 ± 4.3 ml · kg · min−1) and 10 women (22.7 ± 2.0 y;
1.64 ± 0.07 m; 61.76 ± 5.28 kg; 42.0 ± 3.1 ml · kg · min−1)
were included in the final analysis.
All participants completed a questionnaire to assess
their ability to participate in physical activity and to ascer-
tain any prior supplementation. Individuals who reported
using substances that could potentially mask the effects of
caffeine were excluded from the study. If participants were
supplements that did not interfere with the effects of
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Fig. 1 Study protocol
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supplementation, and diet regiment so that the only
difference between trials was the ingestion of TC or
DC. Individuals self-reported to be free of musculosk-
eletal injury as determined by a PAR-Q. Participants
were excluded if they had any history of cardiovascular
disease, metabolic, renal, hepatic, or musculoskeletal
disorders or were taking any other medication as deter-
mined by the medical history questionnaire. Following
an explanation of all procedures, risks and benefits,
each participant provided his/her informed consent to
participate in the study. The Institutional Review Board
of the University of Central Florida approved the re-
search protocol.Treatment beverages
During each experimental trial, participants ingested
either TC or DC 60-min prior to the 5 km time trial.
Participants were provided 0.136 g coffee · kg−1 BW
mixed in 200 ml of boiling water, resulting in 3 mg · kg−1
BW of caffeine per serving (e.g., for a participant with an
average body weight of 70 kg, this was equivalent to 1.5
teaspoons of coffee powder). The Turkish coffee provided
is marketed as Elite Turkish Coffee (Strauss Coffee, Lod,
Israel) and the content provided was recommended by the
manufacturer. There was no difference in appearance or
taste between the TC and DC.Blood sampling
During each experimental trial, all blood samples were
obtained using a 20-gauge Teflon cannula placed in a
superficial forearm vein using a three-way stopcock with
a male luer lock adapter. The cannula was maintained
patent using an isotonic saline solution (Becton Dickinson,
Franklin Lakes, NJ). Blood samples were collected at BL,
30+, PRE, and IP into a Vacutainer® tube, containing
sodium heparin, and was kept chilled prior to each blood
draw. Following collection samples were subsequently
centrifuged at 4,000 × g for 15 min. The resulting plasma
was placed into separate 1.8-mL microcentrifuge tubes
and frozen at −80 °C for later analysis.Biochemical analysis
Of the 20 participants to complete the study 4 requested
to not have blood drawn, thus a sample size of n = 16
was used for blood measures. Plasma glucose and lactate
concentrations were determined using an automated
analyzer (Analox GM7 enzymatic metabolite analyzer,
Analox instruments USA, Lunenburg, MA). To elimin-
ate inter-assay variance, all samples were analyzed in
duplicate by a single technician. Coefficient of vari-
ation for each assay was 2.60 % for glucose and 0.79 %
for lactate.
Plasma caffeine concentrations were quantified using
high performance liquid chromatography (HPLC) with
chromatographic conditions based upon previous work
done in our lab [19]. Chromatography was performed
on an Agilent Infinity 1260 HPLC (Agilent Techno-
logies, Santa Clara, CA) consisting of a degasser, binary
pump, auto-sampler, column thermostat, and photo-
diode array detector. A Zorbax Eclipse Plus C18 (4.6 ×
150 mm, 5-μm) column and Zorbax analytical guard
column (4.6 × 12.5 mm, 5-μm) were used for separation.
Data were collected using OpenLAB chromatography data
system, ChemStation edition.
All reagents were of HPLC grade. Caffeine, beta-
hydroxyethyl-theophylline, sodium phosphate mono-
basic and sodium phosphate dibasic were purchased
from Sigma-Aldrich (St. Louis, MO) to create the
stock solution. Acetonitrile was purchased from Fisher
Scientific (Pittsburgh, PA). HPLC grade water was pre-
pared by reverse-osmosis and purified using a Milli-Q
Direct 8 water purification system (EMD Millipore,
Billerica, MA).
A 40 μg∙mL−1 stock solution of caffeine, theobromine
and beta-hydroxyethyl-theophylline was prepared in water
and sonicated. Twelve calibration standards were prepared
from the stock solution in the range of 0.039 – 40 μg∙mL−1
by serial dilution of 1 mL of the stock solution. Beta-
hydroxyethyl-theophylline (internal standard) working
solution was prepared in water (10 μg∙mL−1).
An internal plasma sample was collected to serve as
control and analyzed every 50 samples. Calibration stan-
dards, samples, and controls were prepared in the same
Church et al. Journal of the International Society of Sports Nutrition  (2015) 12:37 Page 4 of 11fashion for linearity. 60 μL of the calibration standards
or 50 μL of sample or quality control sample was added
to 1.5 mL microcentrifuge tubes. 10 μL of the internal
standard was subsequently added to the samples and
controls, followed by 140 μL of chilled acetonitrile for
deproteinization. Standards, samples, and controls were
then vortexed vigorously for 30 s and placed in a re-
frigerator (4 °C) for two hours followed by centrifugation
at 14,000 g for 15 min in a microcentrifuge to allow the
protein to form a pellet. The supernatant (150 μL) was
collected and subsequently transferred to a 0.45 μm
polytetrafluoroethylene syringeless filter vial (GE Health-
care Mini-Uniprep™, Piscataway, NJ). A concentration of
300 μL of sodium phosphate buffer (mobile phase) was
then added to the vial. The solution was filtered and
injected into the HPLC using an auto-sampler.
The mobile phase consisted of 25 mM sodium phos-
phate (pH 7.0 ± 0.05 at 40 °C) and acetonitrile at a vol-
ume to volume ratio of 90:10. Buffer pH was achieved
by mixing 5.41 g sodium phosphate monobasic anhyd-
rous, and 7.80 g sodium phosphate dibasic anhydrous in
4 L of water at 40 °C. Buffer composition was calculated
using Buffer Maker computer software (Marki, Poland)
and verified using an Oakton pH 11 portable meter
(Oakton Instruments, Vernon Hills, IL). Analysis was
carried out under isocratic conditions via binary mixing of
aqueous and organic phases at a flow rate of 1.5 mL∙min−1
under a system pressure of approximately 90 bars. Chro-
matograms were recorded at 275 nm with a run time of
6 min. Duplication of retention times for a known standard
was used to verify column equilibrium prior to analysis.
Cardiovascular measures
Heart rates and blood pressure (BP) were measured at each
assessment time point using a wireless heart rate monitor
(Polar® RS800CX, Kempele, Finland) and a mobile mercury
sphygmomanometer (American Diagnostic Corporation
Diagnostix™ 972, Hauppauge, New York).
Subjective measures
Participants were instructed to assess their subjective feel-
ings of energy, alertness, and focus using a 15-cm visual
analog scale (VAS). The scale was anchored by the words
“Lowest” and “Highest” to represent extreme ratings where
the greater measured value represents the greater feeling.
Questions were structured as “My level of energy is”, “My
level of alertness is”, and “My level of focus is”. The validity
and reliability of VAS in assessing subjective feelings have
been previously established [20].
Performance measures
Upper body reaction measurements
Measurement of upper body reaction time was performed
on the Dynavision D2 Visuomotor Training Device (D2;Dynavision International LLC, West Chester, OH). The
D2 is a light-training reaction device developed to train
sensory motor integration through the visual system [21].
It consists of a board (4 ft x 4 ft) that can be raised or low-
ered relative to the height of the participant. It contains 64
target buttons (lights) arranged into five concentric circles
surrounding a center screen that can be illuminated to
serve as a stimulus for the participant. Participants were
required to assume a comfortable athletic stance and
stand at a distance from the board where they can eas-
ily reach all of the lights. The board height was kept
consistent for all testing trials and was adjusted per
participant so the center screen was located just below
eye level. A total of three different reaction tests were
conducted.
The first assessment measured the participant’s ability
to react to a stimulus (light) as it changed position on
the board. An initial stimulus (light) was present on the
D2 in a random location. The stimulus (light) remained
lit until it was touched by the participant. A stimulus
(light) then appeared at another random location. The
participant was instructed to successfully identify and
touch as many stimuli (lights) as possible within 60 s.
The number of successful “hits” was recorded for each
trial. The ICC of this assessment has been reported to
be 0.75 in our laboratory [21].
The second assessment was similar to the previous
measure in that participants were also required to react
to a visual stimulus (light) as it changed position on the
board. However, during this trial the stimulus (light)
remained lit for 1 s before it changed to another random
location and the participant had to verbally recite a five
digit number that was presented on the center screen of
the D2 every 5 s. The appearance of the digits placed a
cognitive demand on the information processing resources
of the participant. The participant was instructed to suc-
cessfully identify and touch each stimulus before it chan-
ged position and score as many touches as possible within
60 s. The number of successful “hits” was recorded for
each trial. The ICC of this test has been reported to be
0.73 in our laboratory [21].
The third assessment measured the participant’s visual,
motor, and physical reaction times to a visual stimulus
with the dominant hand. The test was initiated when the
participant placed and held his hand on an illuminated
“home” button. At this point, a stimulus (light) was pre-
sented randomly in one of five locations, parallel to the
home button. Visual reaction time was measured as the
amount of time it takes to identify the stimulus (light)
and initiate a reaction by taking their hand off the home
button. Motor response time was measured as the
amount of time it takes to physically touch the stimulus
(light) with their hand following the initial visual reac-
tion and was measured as the amount of time between
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stimulus (light). Physical reaction time was measured
as the total elapsed time from the introduction of the
target stimulus (light) to the physical completion of the
task (returning to the home button after touching the
stimulus). All measures were recorded to the 1/100’s of
a second. Participants performed this assessment ten
times. The average time for all ten assessments was re-
corded. In our laboratory, the ICC of this test has been
shown to be 0.84 (visual) and 0.63 (motor) [21].
Lower body reaction measurements
Lower body reaction time was measured using a 20-s
reaction test on the Quick Board™ (The Quick Board,
LLC, Memphis, TN) reaction timer. Participants stood
on a board of five circles in a 2 x 1 x 2 pattern. Partici-
pants straddled the middle circle and reacted to a visual
stimulus located on a display box that depicts one of five
potential lights that corresponded with the circles on the
board. Upon illumination of a light, the participant
attempted to move the dominant foot to the circle that
corresponds to the visual stimulus. Upon a successful
“hit” with the foot, the next stimulus appeared. The
total number of successful attempts during the 20-s
test and the average time between the activation of the
light and the response to the corresponding circle was
recorded. The ICC of the Quick Board™ has consist-
ently shown r > 0.90 in our laboratory [19, 22].
Metabolic measures
Peak oxygen consumption (VO2peak) testing
During the familiarization trial an incremental test to
volitional exhaustion was performed on a motorized
treadmill (Woodway 4Front™, Waukesha, WI) to meas-
ure VO2peak. Open-circuit spirometry (TrueOne 2400®
Metabolic Measurement System, Parvo Medics, Inc.,
Sandy, UT) was calibrated with room air and gases of
known concentration, which was used to estimate VO2
(ml∙kg−1∙min−1) by sampling and analyzing breath-by-
breath expired gases. VO2peak was determined to be the
highest 30-s VO2 value during the test and coincided with
at least two of the following three criteria: (a) 90 % of age-
predicted maximum heart rate; (b) respiratory exchange
ratio > 1.1; and/or (c) a plateau of oxygen uptake (less than
150 mL ·min−1 increase in VO2 during the last 60 s of the
test). Previous work in our lab has shown the test-
retest reliability for VO2peak to be ICC = 0.96 (SEM
1.4 ml.kg.min−1) [23].
5 km time trial measures
Prior to each 5 km time trial, open-circuit spirometry
was calibrated with room air and gases of known concen-
tration, which was used to estimate VO2 (ml∙kg
−1∙min−1)
by sampling and analyzing breath-by-breath expired gases.Expired gases—oxygen (O2), carbon dioxide (CO2), VE,
RER, and heart rate were monitored continuously and
expressed as 30-s averages. Ratings of perceived exertion
(RPE) were recorded every 5-min during the time trial.
The time needed to complete the 5 km was recorded to
the nearest tenth of a second.
Multiple object tracking and cognitive assessments
Subsequent to the removal of the intravenous catheter,
after the IP blood draw, the participants were assessed
for multiple object tracking using a Cave Automatic Vir-
tual Environment (CAVE) system. The CAVE consists of
a 7 ft × 7 ft × 7 ft room that includes a canvas projection
screen on the front wall which served as the surface for
image projection. During each session, the participant
wore three dimensional glasses. A three-dimensional image
of 8 tennis balls was projected onto the front screen. The
participant tracked 4 of the 8 balls that moved in three-
dimensions. At the beginning of each trial, the 8 balls
appeared frozen on the screen for 2 s while half of them
turned grey indicating the balls the participant was to
track. After the 2 s, the balls all became the same color
again and began to move in three dimensions. At the
conclusion of the trial (8 s), the balls froze and a number
appeared on each ball. The participant called out the num-
bers of the four balls they were supposed to be tracking.
Velocity of movement began at a slow tracking speed and
increased or decreased depending on whether the partici-
pant correctly identified the 4 correct balls. Each parti-
cipant performed 20 trials per session. The velocity of
movement that was most successful was recorded. Our la-
boratory has previously reported the ICC of this test to be
0.77 [24].
Statistical analysis
Prior to statistical procedures, all data was assessed for
normal distribution, homogeneity of variance, and
sphericity. If assumption of sphericity were violated, a
Greenhouse-Geisser correction was applied. Time trial
and reaction time performance measures were ana-
lyzed with paired student’s t tests. Comparisons be-
tween trials were further analyzed using Cohen’s d.
Cohen’s d values of 0.20, 0.50, and 0.80 were inter-
preted as small, medium, and large effect sizes, respect-
ively [25]. All other measures were analyzed using a 2 x 4
[Trial (TC, DC) x Time (BL, +30, PRE, IP)] repeated mea-
sures analysis of variance (ANOVA). In the event of a
significant interaction, LSD post-hoc tests were used for
pairwise comparisons. Due to a significant difference at
BL for the VAS energy response, a repeated measures ana-
lysis of covariance (ANCOVA) with BL measures serving
as the covariate was used for this measure. For effect size,
the partial eta squared statistic was calculated, and 0.01,
0.06, and 0.14 were interpreted as small, medium, and
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examined the effect of the trials in those participants
that were determined to be responders. A responder
was defined as a participant whose time for the 5 km
time trial was faster during the TC trial compared to
the DC trial. Significance was accepted at an alpha level
of p ≤ 0.05. All data are reported as mean ± SD. Statistical




Changes in plasma caffeine concentrations are displayed
in Fig. 2. A significant interaction was observed between
trials in plasma caffeine concentrations (F = 65.6, p < 0.001,
η2 = 0.814). Significant elevations were observed at 30+,
PRE and IP and each measure was significantly greater
(p < 0.001) for TC than DC.
Plasma glucose and lactate concentrations
No significant interactions were noted between trials
in plasma glucose (F = 1.463, p = 0.245, η2 = 0.089) or
lactate (F = 1.711, p = 0.211, η2 = 0.102). A main effect
for time (F = 47.5, p < 0.001, η2 = 0.760) was seen for
glucose. Significant elevations (p < 0.001) in plasma



































Fig. 2 Plasma caffeine concentrations. * = Indicates significantly higher comto IP (7.74 ± 1.9718.5 mmol/L) for both groups. In
addition, a significant main effect for time (F = 195.85,
p < 0.001, η2 = 0.929) was observed in the plasma lac-
tate response to exercise. Similarly, plasma lactate concen-
trations were significantly elevated (p < 0.001) from BL
(2.29 ± 0.33 mmol/L) to IP (9.34 ± 0.49 mmol/L) for both
groups.
Blood pressure measures
Blood pressure responses can be observed in Fig. 3. No
significant interaction was noted between trials in systolic
blood pressure (F = 1.121, p = 0.323, η2 = 0.056). When
comparing groups across time, a significant main effect was
observed (F = 65.7, p < 0.001, η2 = 0.776). Significant eleva-
tions (p < 0.001) in systolic blood pressure were observed
from BL (115.0 ± 8.4 mmHg) to IP (140.4 ± 18.5 mmHg) in
both groups. In addition, there was a significant main effect
for trial (F = 6.089, p = 0.023, η2 = 0.243) indicating that
systolic blood pressures were elevated during TC compared
to DC when collapsed across all time points. Analysis of
diastolic blood pressure responses revealed no signi-
ficant interactions (F = 1.937, p = 0.134, η2 = 0.092).
However, a significant main effect for time was noted
(F = 13.32, p < 0.001, η2 = 0.412), indicating that when com-
paring trials across time, significant decreases (p = 0.008)






















SBP TC SBP DC DBP TC DBP DC
Fig. 3 Blood pressure response during trials. All values are reported as mean ± SD
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were noted.
Subjective measures of energy, alertness and focus
Changes in subjective measures can be seen in Fig. 4. A
significant interaction was noted between trials for sub-
jective measures of energy (Fig. 4a) (F = 7.637, p = 0.007,
η2 = 0.310). After adjusting for BL differences the adjusted
group means were higher during TC at 30+ and PRE com-
pared to DC, and lower during TC at IP compared to DC.
No significant interaction (Fig. 4b; F = 2.231, p = 0.122,
η2 = 0.105) was observed between trials in alertness.
However, analysis of the main effect for trial indicated a
trend (F = 3.775, p = 0.067, η2 = 0.166) between groups
across time, suggesting that alertness during TC (10.12 ±
0.50) tended to be higher than DC (9.52 ± 0.58). No signifi-
cant interaction (Fig. 4c; F = 1.320, p = 0.277, η2 = 0.065)
were noted between trials in focus. However, analysis of the
main effect for trial indicated a trend (F = 3.189, p = 0.090,
η2 = 0.144) between groups across time, suggesting that
focus tended to be higher during TC (10.16 ± 0.50) com-
pared to DC (9.54 ± 0.61).
Reaction measures
The average number of “hits” in 60 s was significantly
greater for TC (85.1 ± 11.7) compared to DC (82.0 ± 13.7)
(p = 0.023, d = 0.57). No significant differences between
TC and DC were observed for visual (0.31 ± 0.06 s versus
0.30 ± 0.03 s, respectively) (p = 0.557, d = 0.14), motor(0.14 ± 0.06 s versus 0.15 ± 0.06 s, respectively) (p = 0.269,
d = 0.26), physical (0.49 ± 0.10 s versus 0.49 ± 0.04 s, re-
spectively) (p = 0.610, d = 0.12), or lower body reaction
time (24.3 ± 4.6 hits versus 25.3 ± 4.4 hits, respectively)
(p = 0.263, d = 0.26).
Time trial performance
No significant difference (p = 0.192, d = 0.30) was ob-
served between TC (1685.0 ± 216.6 s) and DC (1717.2 ±
255.7 s) in time to complete the 5 km time trial. How-
ever, average RER during the time trials was significantly
greater for TC (0.98 ± 0.05) compared to DC (0.96 ± 0.05)
(p = 0.019, d = 0.57). No significant differences between
TC and DC were observed for average HR (174.5 ±
8.7 bpm and 175.2 ± 9.0 bpm, respectively) (p = 0.623,
d = 0.11), average VO2 (35.63 ± 4.20 ml · min · kg
−1
and 35.23 ± 4.70 ml · min · kg−1, respectively) (p = 0.415,
d = 0.19), average VE (77.1 ± 13.2 L∙min
−1 and 71.9 ±
17.8 L∙min−1, respectively) (p = 0.099, d = 0.39) and aver-
age RPE (13.4 ± 1.5 and 13.5 ± 1.9, respectively) (p = 0.774,
d = 0.06).
When examining individual performance results in the
5 km time trial (see Fig. 5) it was observed that 12 of the
20 participants (6 males and 6 females) ran the 5 km fas-
ter when consuming TC than when consuming DC.
When comparing performance differences in these 12
responders, a 5.0 % difference (p = 0.009) was seen in
time for the 5 km time trial between TC (1685 ± 249 s)
























































Fig. 4 Subjective measures of energy, alertness, and focus.* = Indicates significantly different at baseline;† = Indicates significant interaction effect
with TC higher than DC at given time point;‡ = Indicates significant interaction effect with DC higher than TC;$ = Indicates significantly lower than
30+ and PRE;§ = Indicates significantly lower than PRE. Enervy values adjusted for the initial differences in BL energy. All values are reported
as mean ± SD. a = Energy; b = Alertness; c = Focus
Fig. 5 Individual 5 km times
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No significant differences between TC and DC were ob-
served for multiple object tracking (1.29 ± 0.68 AU versus
1.35 ± 0.53 AU, respectively) (p = 0.643, d = 0.11).Discussion
The present study is the first investigation to examine the
ergogenic benefits and metabolic responses of Turkish
coffee. The results of this study indicated that plasma caf-
feine concentrations were significantly elevated within
30 min following TC ingestion. Participants consuming
TC experienced significantly greater reaction performance
and subjective feelings of energy. Although no significant
differences were noted in time trial performance, during
the TC time trial participants experienced a significantly
higher average RER than that seen during the DC trial,
suggesting a higher utilization of carbohydrate to meet
metabolic demands. Our results are not consistent with
previous investigations which have shown either a de-
crease or no effect of caffeine on RER [3, 9, 27, 28]. Al-
though speculative, differences in the exercise protocol
utilized in this study may have contributed to these con-
trasting results. In the present study a time trial protocol
was used, while other studies employed a time to exhaus-
tion protocol. The goal of a time trial is to complete the
distance in as fast a time as possible, whereas a time to
exhaustion protocol requires the participant to exercise at
a predetermined pace. As such, if the goal is to complete a
given distance as fast as possible the RER would be greater
than that seen during a set-paced trial. Previous research
has reported that coffee ingestion can increase average
power output during a time trial [4]. In addition, caffeine
is a known central nervous system stimulator acting as an
adenosine antagonist, and subsequently increasing sympa-
thetic nervous system activity [4, 11]. Although no signifi-
cant differences were noted in time trial performance, the
greater RER response, and a trend observed in the VE
response during the TC trial, does suggest a greater anaer-
obic effort during the run. This is also consistent with the
greater perceived energy reported by participants during
TC compared to DC. Interestingly, 60 % of the subjects
(12/20) ran faster during the 5 km time trial during TC
compared to DC. When comparisons between TC and
DC were performed in the responders only, the time dif-
ferentials between trials were significantly different. Al-
though speculative, the 60 % responder rate is similar to
the 61.1 % frequency observed in habitual coffee drinkers
possessing a gene associated with enhanced cytochrome
P450 1A2 [29]. Cytochrome P450 is a liver enzyme that is
involved with caffeine metabolism [30]. Thus, those
individuals with this polymorphism would potentially
have a faster metabolism of caffeine, and potentially have
a greater ergogenic response [29, 30].Coffee and caffeine have been associated with enhan-
cing the ability to perform mental tasks, including en-
hanced alertness and attention during activities of daily
living and physical activity [19, 31–33]. Results of this
study showed significant increases in subjective mea-
sures of energy, with trends demonstrated in alertness,
and focus during the TC trial. Greater feelings of energy
at 30+ and PRE corresponded to the significant eleva-
tions in plasma caffeine concentrations. These results
are in agreement with other investigations showing that
a 300–600 mg dose of caffeine can provide beneficial ef-
fects on measures of sleepiness, vigor, fatigue, and atten-
tiveness [19, 31, 34–36]. The lower feelings of energy in
conjunction with a 7 % increase in VE, and greater carbo-
hydrate utilization in TC compared to DC likely reflects a
higher running velocity used during this trial. The differ-
ences in subjective feelings of energy at IP were more diffi-
cult to explain and may be spurious.
In the current study, average upper body reaction time,
measured as the number of successful “hits” in 60 s, was
significantly improved for the TC trial compared to DC.
This is consistent with previous studies that have observed
improved reaction performance with caffeine ingestion
[35, 36]. Although improvements were not noted in all
reaction drills, it is likely that the testing duration of the
visual, motor and physical upper body reaction test, and
the lower body quickness assessment was not sufficient to
yield significant changes. Additionally no significant ef-
fects were noted in any of the cognitive function assess-
ments. Although caffeine is known to have positive effects
on simple reaction time and visuo-spatial reasoning in a
dose-dependent manner [34], the effects of caffeine on
cognition is not as well supported [12, 21]. The present
study enrolled participants who were regular consumers
of caffeine. Chronic ingestion of caffeine (3 mg · kg−1 BW)
has been shown to have no beneficial effects on a four-
choice reaction time test, or on measures of alertness and
attention [37]. The present study may not have provided
enough caffeine for habitual users to demonstrate benefi-
cial effects on attention, which may have affected their
performance on tests of cognitive abilities.
Circulating plasma glucose and lactate were elevated
following exercise, but no differences were noted between
trials. This is consistent with some studies [3, 27, 28, 38],
but in contrast to others [4]. Hodgson and colleagues [4]
reported significant increases in plasma glucose concentra-
tions at the end of a 30-min steady state cycling protocol
following caffeinated coffee ingestion (5 mg caffeine · kg−1
BW). Studies that did not see any difference in the glucose
or lactate response, including the present study, provided
equivalent caffeine doses ranging from 3.0 mg - 4.5 mg caf-
feine · kg−1 BW dose [3, 39]. It appears that caffeine doses
of 5 mg · kg−1 or greater appear necessary to significantly
elevate plasma glucose.
Church et al. Journal of the International Society of Sports Nutrition  (2015) 12:37 Page 10 of 11The time course of caffeine elevation following the con-
sumption of Turkish coffee seen in this study was similar
to that seen following the ingestion of instant coffee [4],
and similar to other investigations investigating caffeine
pharmacokinetics [3, 10, 28]. Acute and chronic ingestion
of coffee or anhydrous caffeine has been shown to cause
an increase in sympathetic nervous system activity and
subsequent increase in systolic blood pressure [11, 40]. Al-
though no significant interactions were noted between the
trials in the systolic blood pressure response, when col-
lapsed across time systolic blood pressures were signifi-
cantly elevated for TC compared to DC, consistent with
the known physiological response following caffeinated
coffee ingestion [41].
Conclusions
Acute ingestion of 3.0 caffeine · kg−1 BW of Turkish cof-
fee results in a significant elevation in plasma caffeine
concentrations within 30 min of consumption. Eleva-
tions in plasma caffeine did appear to result in signifi-
cant performance benefits in reaction time during a 60-s
visual response stimulus and increased subjective feel-
ings of energy in habitual caffeine users. Although no
significant effects were noted in time trial performance
during a 5 km run, 60 % of the participants were deemed
responders and performed significantly faster (5 %) in
the 5 km when consuming Turkish coffee compared to
the decaffeinated trial. No significant benefits though
were noted in measures of cognitive function. Consider-
ing the paucity of research on performance and Turkish
coffee consumption, additional research examining the
ergogenic benefits of pre-exercise ingestion appears
warranted.
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